Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:135 (19 July), doi:10.1136/bmj.327.7407.135
Rana S Hinman, tutor1, Kay M Crossley, postdoctoral research fellow1, Jenny McConnell, senior fellow1, Kim L Bennell, associate professor1
1 Centre for Sports Medicine Research and Education, School of Physiotherapy, University of Melbourne, Victoria, 3010, Australia
Correspondence to: R S Hinman ranash{at}unimelb.edu.au
Design Randomised single blind controlled trial with three intervention arms (therapeutic tape, control tape, and no tape) of three weeks' duration and three week follow up.
Setting Outcome assessment was performed in a university based laboratory. Taping interventions were applied by eight physiotherapists in metropolitan private practice.
Participants 87 patients with symptoms of knee osteoarthritis as defined by the American College of Rheumatology.
Main outcome measures Primary outcome measure was pain as measured by visual analogue scale and participant perceived rating of change. Secondary measures of pain and disability included the Western Ontario and MacMaster Universities osteoarthritis index, knee pain scale, and the SF-36.
Results The therapeutic tape group reported a greater reduction in pain on all primary outcomes than either of the other two groups. A significant association was evident between intervention and change in pain at three weeks (P=0.000), with 73% (21/29) of the therapeutic tape group reporting improvement compared with 49% (14/29) of the control tape group and 10% (3/29) of the no tape group. Significantly greater improvement in pain and disability was observed on most secondary outcomes in the therapeutic tape group compared with the no tape group. Benefits of therapeutic tape were maintained three weeks after stopping treatment.
Conclusions Therapeutic knee taping is an efficacious treatment for the management of pain and disability in patients with knee osteoarthritis.
All participants gave written informed consent then were randomised to receive either therapeutic tape, control tape, or no tape. Immediately after baseline assessment by a blinded assessor, the treating physiotherapist accessed the allocation schedule from a centrally located locked cabinet.
Protocol
The trial comprised a three week intervention period and a three week
follow up. Participants were assessed before treatment (baseline), after three
weeks of treatment (final assessment), and at six weeks (follow up). Tape was
applied by 12 trained physiotherapists at the university (n=4) and in private
practice (n=8) around the metropolitan region. The tape was worn for three
weeks and reapplied weekly.
Therapeutic tape (rigid strapping tape and hypoallergenic undertape) provided medial glide, medial tilt, and anteroposterior tilt to the patella (fig 1). As inflamed soft tissue is aggravated by stretch, tape was also applied to unload either the infrapatellar fat pad or the pes anserinus (determined by clinical assessment to ascertain the most tender).8 Control tape aimed to provide sensory input only. Hypoallergenic tape alone was laid over the same areas of skin as the therapeutic tape. Participants allocated to the no tape group received no intervention. All participants continued current treatments but were instructed to refrain from starting new ones. Analgesic use was recorded in a diary.
|
Participants were unaware of which taping technique was considered therapeutic. Assessments were performed by one assessor (RH), who remained blinded to treatment allocation until after statistical analyses.
Outcome measures and statistical analysis
Primary outcome
The primary outcome was change in pain, measured on an 11 point, 10 cm
horizontal visual analogue scale, numbered in 1 cm
increments.9
Participants rated the average severity of knee pain, over the previous week,
on movement and during an aggravating activity nominated by the participant,
by selecting an appropriate whole number. Participant perceived rating of
change in pain was recorded on a 5 point Likert scale ranging from 1 (much
worse) to 5 (much better). Participants with scores of 4 or 5 were considered
"improvers."
Secondary outcomes
Secondary measures of pain included the pain subscale of the Western
Ontario and MacMaster Universities osteoarthritis index, the knee pain scale,
and the bodily pain domain of the
SF-36.10-12
Disability was measured on a visual analogue scale (average restriction of
activity), the physical function subscale of the osteoarthritis index, and the
physical function and role domains of the SF-36. Analyses were performed with
SPSS software on an intention to treat basis.
|
Primary outcome measures
After intervention the therapeutic tape group showed a significantly
greater reduction in pain than the control and no tape groups
(table). Effect sizes were
large. A small, although non-significant, benefit of control tape was
observed. On most comparisons at six weeks, a significantly greater reduction
in pain from baseline was evident in the therapeutic tape group. This
indicates a prolonged effect of therapeutic tape three weeks after stopping
treatment. An association was evident between group and perceived improvement
in pain after three weeks (
2 test P=0.000;
fig 2), with 21 (73%)
participants in the therapeutic tape group reporting improved pain compared
with three (10%) in the no tape group (95% confidence interval of difference
42% to 82%), and corresponding to a number needed to treat of 2 (1.8 to 2.2).
Compared with no tape group, the therapeutic tape group was seven times more
likely to report improved pain (relative risk 7.00, 2.34 to 20.92), and the
control tape group was four and a half times more likely (4.67, 1.50 to
14.53).
|
Secondary outcome measures
The therapeutic tape group experienced a significantly greater reduction in
pain and disability on most secondary outcomes than the no tape group.
Although control tape achieved small beneficial effects, most differences were
not significantly different from no tape. Although therapeutic tape seemed
more effective than control tape, differences were small for most outcomes and
were not statistically significant. However, at six weeks both tape groups
showed significant improvements from baseline compared with the no tape
group.
Compliance, cointerventions, and adverse effects
Minor skin irritations affected eight (28%) participants in the therapeutic
tape group and one (3%) participant in the control tape group, but all
participants continued to wear the tape as prescribed. One participant (no
tape group) underwent corticosteroid injection for the knee during the
intervention period, and one participant (dropout from no tape group) sought
alternative treatment after the intervention period. No differences were found
in analgesic use between groups over the intervention period (28% no tape
(eight participants), 14% control tape (four), and 31% therapeutic tape
(nine),
2 test P=0.27).
Only one previous study evaluated the effects of knee tape in a population with osteoarthritis.14 Despite the limitations of that trial (small sample, lack of untaped control group, short intervention period, and limited outcome measures), a 25% reduction in pain was observed in patients with patellofemoral joint disease after taping of the patella medially for four days.14 We achieved a greater reduction in pain (38-40%) with therapeutic tape, probably because of our different protocol. Our study expands on previous findings by showing improvements in both pain and physical function using a battery of outcome measures. More importantly, we observed beneficial effects of knee taping in people with generalised, non-specific degeneration of the knee joint. Our cohort comprised patients with both varied severity of disease, as shown by radiography, and varied involvement of the patellofemoral joint. Contrary to the previous trial, some of our participants had only tibiofemoral joint disease, highlighting the generalisability of this intervention to the wider population with osteoarthritis.14 Our study provides the first evidence of the prolonged effects of knee taping in the short term, once treatment has stopped.
Strengths and limitations of study
A strength of our study is the general applicability of the therapeutic
taping technique. Numerous physiotherapists, of varying ages and skill level,
representative of those working in private practice, applied the intervention.
The results suggest that specialist physiotherapists are not required for this
intervention to be effective. The effect sizes were generally medium to large
for most outcome measures, comparable with those reported for exercise
programmes, physiotherapy regimens, and drug
therapies.6
15-17
The main limitation of our study was its short duration, although in clinical practice taping is viewed as a short term and intermittent treatment strategy, generally used as an adjunct to exercise and drug therapies in knee osteoarthritis.
Our cohort comprised volunteers from the community, which explains the large number excluded. Participants had moderately severe osteoarthritis, as assessed by radiography, and reported moderate levels of pain and disability. More women than men were enrolled. We believe that our cohort reflects patients with knee osteoarthritis presenting to health practitioners. Although patients who volunteer for research may be more motivated than those recruited from waiting lists, and thus more likely to report positive outcomes, the lack of significant change in the control tape group suggests that benefits with therapeutic tape were owing to the intervention.
It is not known how taping relieves pain. Subtle changes in patellar position may alter the magnitude or distribution of patellofemoral joint pressures or stress on joint structures.8 Unloading the fat pad may reduce strain on this often inflamed soft tissue.18 Changes in proprioceptive acuity, quadriceps strength, and neuromotor control of the knee with taping have been described in other populations.19-23
|
This is an abridged
version; the full version is on
bmj.com We thank Mike Smith for evaluating the radiographs and the physiotherapists for applying the tape. KMC is a postdoctoral research fellow of the National Health and Medical Research Council Australia.
Contributors: See bmj.com
Funding: National Health and Medical Research Council (grant No 114277) and the Australia New Zealand Charitable Trusts.
Competing interests: JMcC receives a royalty from sales of Endura-Tape (Sydney, Australia). Endura tape was not used in this study.
Ethical approval: The university human research ethics committee approved the study.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care